Week 24 HBeAg and HBsAg are better predictors of sustained response for Chinese HBeAg positive chronic hepatitis B patients receiving 48 weeks Peginterferon α-2b therapy

被引：0
|
作者：
Yang, Song [1 ]
Xing, Huichun [1 ]
Wang, Qixin [2 ]
Xu, Daozhen [1 ]
Cheng, Jun [1 ]
机构：
[1] Beijing Ditan Hosp, Ctr Hepatol, Beijing, Peoples R China
[2] Merck & Co Inc, Beijing, Peoples R China
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
958
引用
收藏
页码：668A / 668A
页数：1
相关论文
共 50 条
  • [1] HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients
    Yang, Song
    Xing, Huichun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Xu, Dongping
    Dong, Peiling
    Wang, Qixin
    Wang, Jue
    Bognar, Fernando A.
    Xu, Daozhen
    Cheng, Jun
    VIROLOGY JOURNAL, 2016, 13 : 1 - 9
  • [2] HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients
    Song Yang
    Huichun Xing
    Yuming Wang
    Jinlin Hou
    Duande Luo
    Qing Xie
    Qin Ning
    Hong Ren
    Huiguo Ding
    Jifang Sheng
    Lai Wei
    Shijun Chen
    Xiaoling Fan
    Wenxiang Huang
    Chen Pan
    Zhiliang Gao
    Jiming Zhang
    Boping Zhou
    Guofeng Chen
    Mobin Wan
    Hong Tang
    Guiqiang Wang
    Yuxiu Yang
    Dongping Xu
    Peiling Dong
    Qixin Wang
    Jue Wang
    Fernando A. Bognar
    Daozhen Xu
    Jun Cheng
    Virology Journal, 13
  • [3] Peginterferon α-2b improves liver histology in Chinese patients with HBeAg positive chronic hepatitis B
    Cheng, J.
    Wang, Y. M.
    Hou, J. L.
    Luo, D. D.
    Xie, Q.
    Ning, Q.
    Huang, Z. F.
    Xu, D. Z.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 137 - 137
  • [4] Twenty-four weeks therapy with Peginterferon alfa-2a is similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response
    Rezzonica, Lucrecia
    Galdame, Omar
    Frider, Bernardo
    Solari, Joaquin
    Villamil, Alejandro
    Casciato, Paolo
    Reig, Maria
    Bandi, Juan
    Alessio, Analia
    Gadano, Adrian
    HEPATOLOGY, 2007, 46 (04) : 673A - 673A
  • [5] EXTENDING PEGINTERFERON ALFA-2A THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B WHO DID NOT ACHIEVE A RESPONSE AT WEEK 48 CAN LEAD TO HBEAG SEROCONVERSION AND HBSAG CLEARANCE
    Chen, Xiao P.
    Chen, Xue-Fu
    Huang, Ji
    Chen, Wen-Li
    Ren, Chen
    Ma, Xiao-jun
    Luo, X-d
    HEPATOLOGY, 2009, 50 (04) : 499A - 499A
  • [6] Early prediction of response to peginterferon for HBeAg-positive chronic hepatitis B using HBsAg levels at week 4 and week 8 of therapy
    Sonneveld, Milan J.
    Brouwer, Willem Pieter
    Zeuzem, Stefan
    Cakaloglu, Yilmaz
    Tabak, Fehmi
    Simon, Krzysztof
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2015, 62 : 1182A - 1182A
  • [7] PREDICTION OF RESPONSE TO PEGINTERFERON FOR HBEAG-POSITIVE CHRONIC HEPATITIS B USING QUANTITATIVE SEROLOGY: HBEAG VERSUS HBSAG
    Sonneveld, M. J.
    Rijckborst, V.
    Hansen, B. E.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S215 - S216
  • [8] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
  • [9] HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    Fried, Michael W.
    Piratvisuth, Teerha
    Lau, George K. K.
    Marcellin, Patrick
    Chow, Wan-Cheng
    Cooksley, Graham
    Luo, Kang-Xian
    Paik, Seung Woon
    Liaw, Yun-Fan
    Button, Peter
    Popescu, Matei
    HEPATOLOGY, 2008, 47 (02) : 428 - 434
  • [10] HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE
    Sonneveld, Milan J.
    Rijckborst, Vincent
    Senturk, Hakan
    Zeuzem, Stefan
    Akarca, Ulus S.
    Simon, Krzysztof
    Gerken, Guido
    Boucher, Charles A.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2010, 52 (04) : 539A - 540A
12345